10-K/A

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

SEC Filing Details

Document Details

Filing Date
Apr 8, 2020
Document Date
Dec 31, 2019
Form Description
Amendment to a previously filed 10-K
Filing Group
Annual Filings
Company
KemPharm
Issuer
KEMPHARM, INC